Curaleaf Holdings, Inc.

CURLFOTCHealthcare● Active

$11.51

+$0.59(+5.40%)

Market Cap$3.0B

P/E Ratio—

52W High$15.15

52W Low$2.16

Avg Volume1.3M

Open$3.48

Beta1.64

Free Cash Flow Financials Revenue

Curaleaf Holdings, Inc. (CURLF) Free Cash Flow & Analysis

Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.

CURLF · free cash flow · updated Jun 9, 2026

Core FCF metrics

CURLF · FCF · TTM · margin & CAGR

Free cash flow was $75.8M for FY2025 (fiscal year ending 2025-12-31), up 14.7% year-over-year The FCF margin was 5.9%.

FY2025 Free Cash Flow$75.8M▲ +14.7% YoY

Trailing 12M (TTM)$54.2Mtrailing 4 quarters sum

FCF Margin5.9%$75.8M ÷ revenue

3-Year CAGRN/AN/A — contains negative FCF

5-Year CAGRN/AN/A — contains negative FCF

FormulaFCF = Operating Cash Flow − Capital ExpendituresTTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /cash-flow-statement · SEC 10-K / 10-Q · USDUpdated: Jun 9, 2026

Annual free cash flow history

FCF ($B, upper) · YoY Growth % (lower)

Positive FCFNegative FCF

Free Cash Flow

YoY Growth %

Annual free cash flow data

CURLF · free cash flow history · annual / quarterly

Fiscal YearOperating CFCapExFree Cash FlowYoY ChangeFCF Margin

FY2025Latest$140.3M(65M)$75.8M▲ +14.7%5.9%

FY2024$154.8M(89M)$66.1M▲ +561.2%5.2%

FY2023$76.6M(67M)$10.0M▲ +111.8%0.7%

FY2022$44.6M(129M)−$84.7M▲ +62.9%-6.9%

FY2021−$57.8M(170M)−$228.2M▼ 90.3%-19.3%

FCF = Operating Cash Flow − Capital Expenditures · CapEx shown as (negative) · Source: SEC filings via FMP

FCF valuation metrics

CURLF · P/FCF · FCF yield · FCF per share

Curaleaf Holdings, Inc. (CURLF) trades at a FCF yield of 1.78% and a price-to-free-cash-flow ratio of 54.8x. FCF per share stands at $0.21, calculated using trailing twelve-month FCF divided by basic weighted-average shares outstanding.

FCF Yield (TTM)

1.78%

Free Cash Flow ÷ Market Cap

per FMP freeCashFlowYieldTTM definition

FCF per Share (TTM)

$0.21

TTM FCF ÷ Shares Outstanding

Price / FCF

x54.8

Share Price ÷ FCF per Share

EV / FCF (TTM)

x73.5

Enterprise Value basis

Source: FMP /key-metrics-ttm · /cash-flow-statement Q · /income-statementFY2025 · 2025-12-31

Cash flow statement summary

CURLF · cash flow statement · operating / investing / financing

For FY2025, Curaleaf Holdings, Inc. generated $140.3M in operating cash flow and spent 65M in capital expenditures, yielding $75.8M in free cash flow.

Operating Activities

+$140.3M

Cash from core business operations

2025-12-31

Investing Activities

−$71.8M

CapEx, acquisitions & investments

2025-12-31

Financing Activities

−$74.8M

Buybacks, dividends & debt

2025-12-31

FCF FormulaOperating CF ($140.3M) − |CapEx| (65M) = FCF ($75.8M)

For the complete Operating / Investing / Financing line-item breakdown:

View Full Cash Flow Statement →

Free cash flow vs peers (Healthcare)

CURLF vs peers · FCF

#CompanyFree Cash FlowYoYFCF MarginRelative

Curaleaf Holdings, Inc.YOU

CURLF

$75.8M+14.7%5.9%

UnitedHealth Group Incorporated

UNH

$16.07B-22.4%3.6%

82%

Eli Lilly and Company

LLY

$8.97B+2065.6%13.8%

46%

Healthcare · Sorted by FCF · FMP /cash-flow-statementFull FCF Rankings →

About Free Cash Flow & Methodology

Curaleaf Holdings, Inc. (CURLF) reported free cash flow of $75.8M for FY2025 (fiscal year ending 2025-12-31), up 14.7% year-over-year. The FCF margin was 5.9%.

Based on available data, Curaleaf Holdings, Inc. has maintained positive free cash flow for at least 3 fiscal year(s). FCF peaked at $75.8M in FY2025.

Curaleaf Holdings, Inc.'s FCF yield is 1.78% and price-to-FCF ratio is 54.8x for FY2025, based on the latest available data.

Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.

Q&A and summaries align with SEC 10-K/10-Q cash flow disclosures and FMP /cash-flow-statement where noted.

Revenue Financial statements Net income Earnings Forecast Price history Market cap Cash on hand P/E ratio

Frequently asked questions

CURLF free cash flow · 8 questions

Curaleaf Holdings, Inc. free cash flow was $75.8M for FY2025, up 14.7% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at $54.2M.

CURLF free cash flowCURLF FCFCURLF FCF 2025CURLF free cash flow TTM

▸ Source: FMP /cash-flow-statement · US GAAP · Curaleaf Holdings, Inc. · Curaleaf Holdings, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 9, 2026